Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Type (2014-2025) 1.4.2 Medicine 1.4.3 Surgery 1.4.4 Other 1.5 Market by Application 1.5.1 Global Androgen Deprivation Therapy (ADT) Market Share by Application (2019-2025) 1.5.2 Hospital 1.5.3 Clinic 1.5.4 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Androgen Deprivation Therapy (ADT) Market Size 2.2 Androgen Deprivation Therapy (ADT) Growth Trends by Regions 2.2.1 Androgen Deprivation Therapy (ADT) Market Size by Regions (2019-2025) 2.2.2 Androgen Deprivation Therapy (ADT) Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 3 Market Share by Key Players 3.1 Androgen Deprivation Therapy (ADT) Market Size by by Players 3.1.1 Global Androgen Deprivation Therapy (ADT) Revenue by by Players (2014-2019) 3.1.2 Global Androgen Deprivation Therapy (ADT) Revenue Market Share by by Players (2014-2019) 3.1.3 Global Androgen Deprivation Therapy (ADT) Market Concentration Ratio (CR5 and HHI) 3.2 Androgen Deprivation Therapy (ADT) Key Players Head office and Area Served 3.3 Key Players Androgen Deprivation Therapy (ADT) Product/Solution/Service 3.4 Date of Enter into Androgen Deprivation Therapy (ADT) Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Androgen Deprivation Therapy (ADT) Market Size by Type (2014-2019) 4.2 Global Androgen Deprivation Therapy (ADT) Market Size by Application (2014-2019) 5 North America 5.1 North America Androgen Deprivation Therapy (ADT) Market Size (2014-2019) 5.2 Androgen Deprivation Therapy (ADT) Key Players in North America 5.3 North America Androgen Deprivation Therapy (ADT) Market Size by Type 5.4 North America Androgen Deprivation Therapy (ADT) Market Size by Application 6 Europe 6.1 Europe Androgen Deprivation Therapy (ADT) Market Size (2014-2019) 6.2 Androgen Deprivation Therapy (ADT) Key Players in Europe 6.3 Europe Androgen Deprivation Therapy (ADT) Market Size by Type 6.4 Europe Androgen Deprivation Therapy (ADT) Market Size by Application 7 China 7.1 China Androgen Deprivation Therapy (ADT) Market Size (2014-2019) 7.2 Androgen Deprivation Therapy (ADT) Key Players in China 7.3 China Androgen Deprivation Therapy (ADT) Market Size by Type 7.4 China Androgen Deprivation Therapy (ADT) Market Size by Application 8 Japan 8.1 Japan Androgen Deprivation Therapy (ADT) Market Size (2014-2019) 8.2 Androgen Deprivation Therapy (ADT) Key Players in Japan 8.3 Japan Androgen Deprivation Therapy (ADT) Market Size by Type 8.4 Japan Androgen Deprivation Therapy (ADT) Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Androgen Deprivation Therapy (ADT) Market Size (2014-2019) 9.2 Androgen Deprivation Therapy (ADT) Key Players in Southeast Asia 9.3 Southeast Asia Androgen Deprivation Therapy (ADT) Market Size by Type 9.4 Southeast Asia Androgen Deprivation Therapy (ADT) Market Size by Application 10 India 10.1 India Androgen Deprivation Therapy (ADT) Market Size (2014-2019) 10.2 Androgen Deprivation Therapy (ADT) Key Players in India 10.3 India Androgen Deprivation Therapy (ADT) Market Size by Type 10.4 India Androgen Deprivation Therapy (ADT) Market Size by Application 11 Central & South America 11.1 Central & South America Androgen Deprivation Therapy (ADT) Market Size (2014-2019) 11.2 Androgen Deprivation Therapy (ADT) Key Players in Central & South America 11.3 Central & South America Androgen Deprivation Therapy (ADT) Market Size by Type 11.4 Central & South America Androgen Deprivation Therapy (ADT) Market Size by Application 12 International Players Profiles 12.1 Pfizer 12.1.1 Pfizer Company Details 12.1.2 Company Description and Business Overview 12.1.3 Androgen Deprivation Therapy (ADT) Introduction 12.1.4 Pfizer Revenue in Androgen Deprivation Therapy (ADT) Business (2014-2019)) 12.1.5 Pfizer Recent Development 12.2 Astellas Pharma 12.2.1 Astellas Pharma Company Details 12.2.2 Company Description and Business Overview 12.2.3 Androgen Deprivation Therapy (ADT) Introduction 12.2.4 Astellas Pharma Revenue in Androgen Deprivation Therapy (ADT) Business (2014-2019) 12.2.5 Astellas Pharma Recent Development 12.3 Johnson & Johnson 12.3.1 Johnson & Johnson Company Details 12.3.2 Company Description and Business Overview 12.3.3 Androgen Deprivation Therapy (ADT) Introduction 12.3.4 Johnson & Johnson Revenue in Androgen Deprivation Therapy (ADT) Business (2014-2019) 12.3.5 Johnson & Johnson Recent Development 12.4 Novartis International 12.4.1 Novartis International Company Details 12.4.2 Company Description and Business Overview 12.4.3 Androgen Deprivation Therapy (ADT) Introduction 12.4.4 Novartis International Revenue in Androgen Deprivation Therapy (ADT) Business (2014-2019) 12.4.5 Novartis International Recent Development 12.5 Merck 12.5.1 Merck Company Details 12.5.2 Company Description and Business Overview 12.5.3 Androgen Deprivation Therapy (ADT) Introduction 12.5.4 Merck Revenue in Androgen Deprivation Therapy (ADT) Business (2014-2019) 12.5.5 Merck Recent Development 12.6 Veru 12.6.1 Veru Company Details 12.6.2 Company Description and Business Overview 12.6.3 Androgen Deprivation Therapy (ADT) Introduction 12.6.4 Veru Revenue in Androgen Deprivation Therapy (ADT) Business (2014-2019) 12.6.5 Veru Recent Development 12.7 Sanofi 12.7.1 Sanofi Company Details 12.7.2 Company Description and Business Overview 12.7.3 Androgen Deprivation Therapy (ADT) Introduction 12.7.4 Sanofi Revenue in Androgen Deprivation Therapy (ADT) Business (2014-2019) 12.7.5 Sanofi Recent Development 12.8 GlaxoSmithKline 12.8.1 GlaxoSmithKline Company Details 12.8.2 Company Description and Business Overview 12.8.3 Androgen Deprivation Therapy (ADT) Introduction 12.8.4 GlaxoSmithKline Revenue in Androgen Deprivation Therapy (ADT) Business (2014-2019) 12.8.5 GlaxoSmithKline Recent Development 12.9 Bayer 12.9.1 Bayer Company Details 12.9.2 Company Description and Business Overview 12.9.3 Androgen Deprivation Therapy (ADT) Introduction 12.9.4 Bayer Revenue in Androgen Deprivation Therapy (ADT) Business (2014-2019) 12.9.5 Bayer Recent Development 12.10 Orion 12.10.1 Orion Company Details 12.10.2 Company Description and Business Overview 12.10.3 Androgen Deprivation Therapy (ADT) Introduction 12.10.4 Orion Revenue in Androgen Deprivation Therapy (ADT) Business (2014-2019) 12.10.5 Orion Recent Development 12.11 AstraZeneca 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Product (2019-2025) 13.2 Market Size Forecast by Application (2019-2025) 13.3 Market Size Forecast by Regions 13.4 North America 13.5 Europe 13.6 China 13.7 Japan 13.8 Southeast Asia 13.9 India 13.10 Central & South America 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 15.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Androgen Deprivation Therapy (ADT) Key Market Segments Table Key Players Androgen Deprivation Therapy (ADT) Covered Table Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Type 2018-2025 (Million US$) Figuer Medicine Figures Table Key Players of Medicine Figuer Surgery Figures Table Key Players of Surgery Figuer Other Figures Table Key Players of Other Table Global Androgen Deprivation Therapy (ADT) Market Size Growth by Application 2019-2025 (Million US$) Figure Global Androgen Deprivation Therapy (ADT) Market Share by Application in 2018 & 2025 Figure Hospital Case Studies Figure Clinic Case Studies Figure Other Case Studies Figure Androgen Deprivation Therapy (ADT) Report Years Considered Figure Global Androgen Deprivation Therapy (ADT) Market Size and Growth Rate 2014-2025 (Million US$) Table Global Androgen Deprivation Therapy (ADT) Market Size by Regions 2019-2025 (Million US$) Table Global Androgen Deprivation Therapy (ADT) Market Size by Regions 2019-2025 (Million US$) Table Global Androgen Deprivation Therapy (ADT) Market Share by Regions 2014-2019 Figure Global Androgen Deprivation Therapy (ADT) Market Share by Regions 2014-2019 Figure Global Androgen Deprivation Therapy (ADT) Market Share by Regions in 2018 Table Market Top Trends Table Key Drivers: Impact Analysis (2019-2025) Table Key Challenges Figure PORTER'S FIVE FORCES ANALYSIS Table Global Androgen Deprivation Therapy (ADT) Revenue by by Players (2014-2019) (Million US$) Table Global Androgen Deprivation Therapy (ADT) Market Share by by Players (2014-2019) Figure Global Androgen Deprivation Therapy (ADT) Market Share by by Players in 2018 Table Global Androgen Deprivation Therapy (ADT) by Players Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Androgen Deprivation Therapy (ADT) Product/Solution/Service Table Date of Enter into Androgen Deprivation Therapy (ADT) Market Table Mergers & Acquisitions, Expansion Plans Table Global Androgen Deprivation Therapy (ADT) Market Size by Type (2014-2019) (Million US$) Table Global Androgen Deprivation Therapy (ADT) Market Size Share by Type (2014-2019) Figure Global Androgen Deprivation Therapy (ADT) Market Size Market Share by Type (2014-2019) Table Global Androgen Deprivation Therapy (ADT) Market Size by Application (2014-2019) (Million US$) Table Global Androgen Deprivation Therapy (ADT) Market Size Share by Application (2014-2019) Figure Global Androgen Deprivation Therapy (ADT) Market Size Market Share by Application (2014-2019) Figure Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Application in 2018 Figure North America Androgen Deprivation Therapy (ADT) Market Size 2014-2019 (Million US$) Table North America Key Players Androgen Deprivation Therapy (ADT) Revenue (2018-2019) (Million US$) Table North America Key Players Androgen Deprivation Therapy (ADT) Market Share (2018-2019) Table North America Androgen Deprivation Therapy (ADT) Market Size by Type 2014-2019 (Million US$) Table North America Androgen Deprivation Therapy (ADT) Market Share by Type 2014-2019 Table North America Androgen Deprivation Therapy (ADT) Market Size by Application 2014-2019 (Million US$) Table North America Androgen Deprivation Therapy (ADT) Market Share by Application 2014-2019 Figure Europe Androgen Deprivation Therapy (ADT) Market Size 2014-2019 (Million US$) Table Europe Key Players Androgen Deprivation Therapy (ADT) Revenue (2018-2019) (Million US$) Table Europe Key Players Androgen Deprivation Therapy (ADT) Market Share (2018-2019) Table Europe Androgen Deprivation Therapy (ADT) Market Size by Type 2014-2019 (Million US$) Table Europe Androgen Deprivation Therapy (ADT) Market Share by Type 2014-2019 Table Europe Androgen Deprivation Therapy (ADT) Market Size by Application 2014-2019 (Million US$) Table Europe Androgen Deprivation Therapy (ADT) Market Share by Application 2014-2019 Figure China Androgen Deprivation Therapy (ADT) Market Size 2014-2019 (Million US$) Table China Key Players Androgen Deprivation Therapy (ADT) Revenue (2018-2019) (Million US$) Table China Key Players Androgen Deprivation Therapy (ADT) Market Share (2018-2019) Table China Androgen Deprivation Therapy (ADT) Market Size by Type 2014-2019 (Million US$) Table China Androgen Deprivation Therapy (ADT) Market Share by Type 2014-2019 Table China Androgen Deprivation Therapy (ADT) Market Size by Application 2014-2019 (Million US$) Table China Androgen Deprivation Therapy (ADT) Market Share by Application 2014-2019 Figure Japan Androgen Deprivation Therapy (ADT) Market Size 2014-2019 (Million US$) Table Japan Key Players Androgen Deprivation Therapy (ADT) Revenue (2018-2019) (Million US$) Table Japan Key Players Androgen Deprivation Therapy (ADT) Market Share (2018-2019) Table Japan Androgen Deprivation Therapy (ADT) Market Size by Type 2014-2019 (Million US$) Table Japan Androgen Deprivation Therapy (ADT) Market Share by Type 2014-2019 Table Japan Androgen Deprivation Therapy (ADT) Market Size by Application 2014-2019 (Million US$) Table Japan Androgen Deprivation Therapy (ADT) Market Share by Application 2014-2019 Figure Southeast Asia Androgen Deprivation Therapy (ADT) Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Androgen Deprivation Therapy (ADT) Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Androgen Deprivation Therapy (ADT) Market Share (2018-2019) Table Southeast Asia Androgen Deprivation Therapy (ADT) Market Size by Type 2014-2019 (Million US$) Table Southeast Asia Androgen Deprivation Therapy (ADT) Market Share by Type 2014-2019 Table Southeast Asia Androgen Deprivation Therapy (ADT) Market Size by Application 2014-2019 (Million US$) Table Southeast Asia Androgen Deprivation Therapy (ADT) Market Share by Application 2014-2019 Figure India Androgen Deprivation Therapy (ADT) Market Size 2014-2019 (Million US$) Table India Key Players Androgen Deprivation Therapy (ADT) Revenue (2018-2019) (Million US$) Table India Key Players Androgen Deprivation Therapy (ADT) Market Share (2018-2019) Table India Androgen Deprivation Therapy (ADT) Market Size by Type 2014-2019 (Million US$) Table India Androgen Deprivation Therapy (ADT) Market Share by Type 2014-2019 Table India Androgen Deprivation Therapy (ADT) Market Size by Application 2014-2019 (Million US$) Table India Androgen Deprivation Therapy (ADT) Market Share by Application 2014-2019 Figure Central & South America Androgen Deprivation Therapy (ADT) Market Size 2014-2019 (Million US$) Table Central & South America Key Players Androgen Deprivation Therapy (ADT) Revenue (2018-2019) (Million US$) Table Central & South America Key Players Androgen Deprivation Therapy (ADT) Market Share (2018-2019) Table Central & South America Androgen Deprivation Therapy (ADT) Market Size by Type 2014-2019 (Million US$) Table Central & South America Androgen Deprivation Therapy (ADT) Market Share by Type 2014-2019 Table Central & South America Androgen Deprivation Therapy (ADT) Market Size by Application 2014-2019 (Million US$) Table Central & South America Androgen Deprivation Therapy (ADT) Market Share by Application 2014-2019 Table Pfizer Company Details Table Pfizer Revenue in Androgen Deprivation Therapy (ADT) Business 2014-2019 (Million US$) Figure Pfizer Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2014-2019) Table Pfizer Recent Development Table Astellas Pharma Company Details Table Astellas Pharma Revenue in Androgen Deprivation Therapy (ADT) Business 2014-2019 (Million US$) Figure Astellas Pharma Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2014-2019) Table Astellas Pharma Recent Development Table Johnson & Johnson Company Details Table Johnson & Johnson Revenue in Androgen Deprivation Therapy (ADT) Business 2014-2019 (Million US$) Figure Johnson & Johnson Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2014-2019) Table Johnson & Johnson Recent Development Table Novartis International Company Details Table Novartis International Revenue in Androgen Deprivation Therapy (ADT) Business 2014-2019 (Million US$) Figure Novartis International Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2014-2019) Table Novartis International Recent Development Table Merck Company Details Table Merck Revenue in Androgen Deprivation Therapy (ADT) Business 2014-2019 (Million US$) Figure Merck Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2014-2019) Table Merck Recent Development Table Veru Company Details Table Veru Revenue in Androgen Deprivation Therapy (ADT) Business 2014-2019 (Million US$) Figure Veru Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2014-2019) Table Veru Recent Development Table Sanofi Company Details Table Sanofi Revenue in Androgen Deprivation Therapy (ADT) Business 2014-2019 (Million US$) Figure Sanofi Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2014-2019) Table Sanofi Recent Development Table GlaxoSmithKline Company Details Table GlaxoSmithKline Revenue in Androgen Deprivation Therapy (ADT) Business 2014-2019 (Million US$) Figure GlaxoSmithKline Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2014-2019) Table GlaxoSmithKline Recent Development Table Bayer Company Details Table Bayer Revenue in Androgen Deprivation Therapy (ADT) Business 2014-2019 (Million US$) Figure Bayer Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2014-2019) Table Bayer Recent Development Table Orion Company Details Table Orion Revenue in Androgen Deprivation Therapy (ADT) Business 2014-2019 (Million US$) Figure Orion Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2014-2019) Table Orion Recent Development Table AstraZeneca Company Details Table Global Androgen Deprivation Therapy (ADT) Market Size by Regions (Million US$) 2019-2025 Figure Global Androgen Deprivation Therapy (ADT) Market Size Share by Regions (2019-2025) Figure Global Androgen Deprivation Therapy (ADT) Market Size Share by Regions in 2025 Figure North America Androgen Deprivation Therapy (ADT) Market Size Forecast (2019-2025)(Million USD) Figure Europe Androgen Deprivation Therapy (ADT) Market Size Forecast (2019-2025)(Million USD) Figure China Androgen Deprivation Therapy (ADT) Market Size Forecast (2019-2025)(Million USD) Figure Japan Androgen Deprivation Therapy (ADT) Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Androgen Deprivation Therapy (ADT) Market Size Forecast (2019-2025)(Million USD) Figure India Androgen Deprivation Therapy (ADT) Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Androgen Deprivation Therapy (ADT) Market Size Forecast (2019-2025)(Million USD) Table Global Androgen Deprivation Therapy (ADT) Market Size by Product (2019-2025) (Million US$) Figure Global Androgen Deprivation Therapy (ADT) Market Size by Product (2019-2025) Figure Global Androgen Deprivation Therapy (ADT) Market Size by Product in 2025 Table Global Androgen Deprivation Therapy (ADT) Market Size by Application (2019-2025) (Million US$) Figure Global Androgen Deprivation Therapy (ADT) Market Size by Application (2019-2025) Figure Global Androgen Deprivation Therapy (ADT) Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Pfizer Astellas Pharma Johnson & Johnson Novartis International Merck Veru Sanofi GlaxoSmithKline Bayer Orion AstraZeneca